Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase.
Nagaoka K, Bai X, Liu D, Cao K, Mulla J, Ji C, Chen H, Nisar MA, Bay A, Mueller W, Hildebrand G, Gao JS, Lu S, Setoyama H, Tanaka Y, Wands JR, Huang CK.
Nagaoka K, et al. Among authors: mulla j.
Cancer Lett. 2024 Jan 1;580:216493. doi: 10.1016/j.canlet.2023.216493. Epub 2023 Nov 15.
Cancer Lett. 2024.
PMID: 37977350